Breast cancer rates continue to rise. From 2012 to 2022, cases increased by 1% each year in women older than 50 and by 1.4% in women younger than 50. Younger women are also more likely to develop aggressive cancers. These cancers often grow faster, appear at later stages, and include tumors that lack hormone receptors or overexpress HER2 protein. This pattern raises the risk for triple-negative breast cancer, a difficult subtype to treat.
The Importance of Early Detection
Early diagnosis is critical. A 2023 analysis of patients with triple-negative breast cancer showed that early-onset cancers can respond better to treatment than cancers found later. Because of this, screening guidelines are evolving.
Current Screening Recommendations
Most major organizations now recommend starting mammograms at age 40. This shift reflects the increasing number of younger women being diagnosed.
Guidelines for Women at Average Risk
ACS: Women 40–44 may begin annual mammograms. Ages 45–54 should receive annual screening. At 55 and older, women may choose yearly or biannual mammograms.
USPSTF: Women should have a mammogram every two years from ages 40 to 74.
ACR: Annual mammograms starting at age 40; more intensive screening for higher-risk individuals.
ACOG: Offer mammograms beginning at age 40.
NCCN: Offer annual screening starting at age 40.
BCRF: Begin mammograms at age 40 and continue every two years until age 74.
Understanding Risk Levels
Average Risk
A woman is considered average risk if she has no symptoms, no family history of breast cancer, no known genetic mutations, and no chest radiation before age 30. The lifetime risk for these women is about 12%.
High Risk
Women with a lifetime risk of 20% to 25% or more fall into the high-risk group. High-risk factors include a BRCA1 or BRCA2 mutation, a first-degree relative with such a mutation, chest radiation before age 30, or genetic syndromes such as Li-Fraumeni, Cowden, or Bannayan-Riley-Ruvalcaba.
Using Breast Cancer Risk Assessment Tools
Lifetime risk is estimated with tools such as the Breast Cancer Risk Assessment Tool, BRCAPro, the Breast Cancer Surveillance Consortium calculator, and the IBIS model. These tools assign risk scores based on factors including:
- Age
- Family history
- Genetic mutations
- ace or ethnicity
- Breast density
- Past breast biopsies
- Hormone exposure
- Early menarche or late menopause
- Childbirth history
Screening Versus Diagnostic Testing
Most screening mammograms now use 3D technology, also called digital breast tomosynthesis. This method creates layered images that detect small tumors and microcalcifications. Diagnostic mammograms are used when screening finds an abnormality or when specific conditions, such as implants, make screening harder.
Women at high risk or with concerning screening results may also need ultrasound or MRI.
Related topics
How Breast Self-Checks Protect Nursing Parents from Hidden Risk
